Q4FY17 Results: Thyrocare Technologies Ltd

Thyrocare Technologies Ltd. reported its results for the quarter ended March 31, 2017, on Tuesday.

Total sales for this quarter, Q4FY17, came in at Rs. 87.67 crores. This represents a 23.37 per cent sequential increase and 34.77 per cent YoY increase.

Operating profit (EBIT) for the recently concluded quarter amounted to Rs. 28.25 crore and the EBIT margin stood at 32.22 per cent.

The reported PAT of Rs. 18.95 crore which represents a sequential QoQ increase of 23.29 per cent and a YoY increase of 36.04 per cent.

The Board of Directors has approved a final dividend of Rs. 5 per equity share for the face value of Rs. 10 each.

In today’s trading session, it had kicked off the day at Rs. 760, almost up by 5.7% from its last closing on BSE. At 10:14 a.m., it was trading at Rs. 738.2 on BSE.

Thyrocare Technologies Limited is an India-based healthcare service provider. The Company operates with a centralised processing laboratory (CPL) in Mumbai, India for esoteric tests, and regional processing laboratory in metro cities of India and other parts of Asia.